642 related articles for article (PubMed ID: 7717222)
1. Blood-pool MR contrast material for detection and characterization of focal hepatic lesions: initial clinical experience with ultrasmall superparamagnetic iron oxide (AMI-227).
Saini S; Edelman RR; Sharma P; Li W; Mayo-Smith W; Slater GJ; Eisenberg PJ; Hahn PF
AJR Am J Roentgenol; 1995 May; 164(5):1147-52. PubMed ID: 7717222
[TBL] [Abstract][Full Text] [Related]
2. Characterization of focal liver lesions with superparamagnetic iron oxide-enhanced MR imaging: value of distributional phase T1-weighted imaging.
Lee JM; Kim CS; Youk JH; Lee MS
Korean J Radiol; 2003; 4(1):9-18. PubMed ID: 12679629
[TBL] [Abstract][Full Text] [Related]
3. Characterization of focal hepatic lesions with ferumoxides-enhanced MR imaging: utility of T1-weighted spoiled gradient recalled echo images using different echo times.
Kim JH; Kim MJ; Suh SH; Chung JJ; Yoo HS; Lee JT
J Magn Reson Imaging; 2002 May; 15(5):573-83. PubMed ID: 11997899
[TBL] [Abstract][Full Text] [Related]
4. Multicentre dose-ranging study on the efficacy of USPIO ferumoxtran-10 for liver MR imaging.
Saini S; Sharma R; Baron RL; Turner DA; Ros PR; Hahn PF; Small WC; Delange EE; Stillman AE; Edelman RR; Runge VM; Outwater EK
Clin Radiol; 2000 Sep; 55(9):690-5. PubMed ID: 10988047
[TBL] [Abstract][Full Text] [Related]
5. [Magnetic resonance imaging of hepatic focal lesions: dynamic contrastographic evaluation with gadolinium versus reticulo-endothelial hepato-specific contrast media].
Di Cesare E; Cariello G; Barile A; Sabatini M; Michelini O; Erriquez D; Masciocchi C
Radiol Med; 2000 Oct; 100(4):245-50. PubMed ID: 11155451
[TBL] [Abstract][Full Text] [Related]
6. Hepatic MRI with SPIO: detection and characterization of focal liver lesions.
Reimer P; Tombach B
Eur Radiol; 1998; 8(7):1198-204. PubMed ID: 9724439
[TBL] [Abstract][Full Text] [Related]
7. [Use of SPIO-enhanced T1- and T2-weighted images for the differentiation of liver lesions: an ROC analysis].
Stroszczynski C; Gaffke G; Gretschel S; Rambow A; Jost D; Schlecht I; Schneider U; Schicke B; Hohenberger P; Gebauer B; Felix R
Rofo; 2003 Oct; 175(10):1368-75. PubMed ID: 14556106
[TBL] [Abstract][Full Text] [Related]
8. MR imaging with i.v. superparamagnetic iron oxide: efficacy in the detection of focal hepatic lesions.
Winter TC; Freeny PC; Nghiem HV; Mack LA; Patten RM; Thomas CR; Elliott S
AJR Am J Roentgenol; 1993 Dec; 161(6):1191-8. PubMed ID: 8249724
[TBL] [Abstract][Full Text] [Related]
9. Detection and characterization of focal liver lesions using superparamagnetic iron oxide-enhanced magnetic resonance imaging: comparison between ferumoxides-enhanced T1-weighted imaging and delayed-phase gadolinium-enhanced T1-weighted imaging.
Takahama K; Amano Y; Hayashi H; Ishihara M; Kumazaki T
Abdom Imaging; 2003; 28(4):525-30. PubMed ID: 14580096
[TBL] [Abstract][Full Text] [Related]
10. Differentiation of liver hemangiomas from metastases and hepatocellular carcinoma at MR imaging enhanced with blood-pool contrast agent Code-7227.
Harisinghani MG; Saini S; Weissleder R; Halpern EF; Schima W; Rubin DL; Stillman AE; Sica GT; Small WC; Hahn PF
Radiology; 1997 Mar; 202(3):687-91. PubMed ID: 9051017
[TBL] [Abstract][Full Text] [Related]
11. Detection and characterization of focal liver lesions: a Japanese phase III, multicenter comparison between gadoxetic acid disodium-enhanced magnetic resonance imaging and contrast-enhanced computed tomography predominantly in patients with hepatocellular carcinoma and chronic liver disease.
Ichikawa T; Saito K; Yoshioka N; Tanimoto A; Gokan T; Takehara Y; Kamura T; Gabata T; Murakami T; Ito K; Hirohashi S; Nishie A; Saito Y; Onaya H; Kuwatsuru R; Morimoto A; Ueda K; Kurauchi M; Breuer J
Invest Radiol; 2010 Mar; 45(3):133-41. PubMed ID: 20098330
[TBL] [Abstract][Full Text] [Related]
12. Ring enhancement in ultrasmall superparamagnetic iron oxide MR imaging: a potential new sign for characterization of liver lesions.
Mergo PJ; Helmberger T; Nicolas AI; Ros PR
AJR Am J Roentgenol; 1996 Feb; 166(2):379-84. PubMed ID: 8553952
[TBL] [Abstract][Full Text] [Related]
13. [Superparamagnetic iron oxide particles: what value has the T1 effect in the MR diagnosis of focal liver lesions?].
Urhahn R; Adam G; Busch N; Chen JH; Euringer W; Günther RW
Rofo; 1996 Oct; 165(4):364-70. PubMed ID: 8963049
[TBL] [Abstract][Full Text] [Related]
14. [Differential diagnosis of focal liver lesions with MRI using the superparamagnetic contrast medium endorem].
Vogl TJ; Hammerstingl R; Keck H; Felix R
Radiologe; 1995 Nov; 35(11 Suppl 2):S258-66. PubMed ID: 8588032
[TBL] [Abstract][Full Text] [Related]
15. Hepatocellular lesions with increased iron uptake on superparamagnetic iron oxide-enhanced magnetic resonance imaging in cirrhosis or chronic hepatitis: comparison of four magnetic resonance sequences for lesion conspicuity.
Tanabe M; Ito K; Shimizu A; Fujita T; Onoda H; Yamatogi S; Washida Y; Matsunaga N
Magn Reson Imaging; 2009 Jul; 27(6):801-6. PubMed ID: 19144487
[TBL] [Abstract][Full Text] [Related]
16. Magnetic resonance imaging of focal liver lesions. Comparison of the superparamagnetic iron oxide resovist versus gadolinium-DTPA in the same patient.
Vogl TJ; Hammerstingl R; Schwarz W; Kümmel S; Müller PK; Balzer T; Lauten MJ; Balzer JO; Mack MG; Schimpfky C; Schrem H; Bechstein WO; Neuhaus P; Felix R
Invest Radiol; 1996 Nov; 31(11):696-708. PubMed ID: 8915751
[TBL] [Abstract][Full Text] [Related]
17. Detection of focal liver lesions with superparamagnetic iron oxide: value of STIR and SE imaging.
Halavaara JT; Lamminen AE; Bondestam S; Standertskjöld-Nordenstam CG; Hamberg LM
J Comput Assist Tomogr; 1994; 18(6):897-904. PubMed ID: 7962796
[TBL] [Abstract][Full Text] [Related]
18. [Dynamic and static MRI using superparamagnetic MRI contrast medium Resovist for visualizing primary and secondary liver tumors].
Vogl TJ; Schwarz W; Hammerstingl R; Kümmel S; Balzer JO; Mack MG; Diebold T; Balzer T; Shamsi K; Bechstein WO; Schrem H; Neuhaus P; Felix R
Rofo; 1997 Sep; 167(3):264-73. PubMed ID: 9376555
[TBL] [Abstract][Full Text] [Related]
19. Ferumoxides-enhanced double-echo T2-weighted MR imaging in differentiating metastases from nonsolid benign lesions of the liver.
Arbab AS; Ichikawa T; Sou H; Araki T; Nakajima H; Ishigame K; Yoshikawa T; Kumagai H
Radiology; 2002 Oct; 225(1):151-8. PubMed ID: 12354999
[TBL] [Abstract][Full Text] [Related]
20. Improved tissue characterization of focal liver lesions with ferumoxide-enhanced T1 and T2-weighted MR imaging.
Nakayama M; Yamashita Y; Mitsuzaki K; Yi T; Arakawa A; Katahira K; Nakayama Y; Takahashi M
J Magn Reson Imaging; 2000 Jun; 11(6):647-54. PubMed ID: 10862064
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]